Related references
Note: Only part of the references are listed.NFIA and NFIB function as tumour suppressors in high-grade glioma in mice
Kok-Siong Chen et al.
CARCINOGENESIS (2021)
Metabolism and function of polyamines in cancer progression
Ita Novita Sari et al.
CANCER LETTERS (2021)
The NFIB-ERO1A axis promotes breast cancer metastatic colonization of disseminated tumour cells
Federica Zilli et al.
EMBO MOLECULAR MEDICINE (2021)
NFIB promotes the progression of gastric cancer by upregulating circMAP7D1 to stabilize HER2 mRNA
Huimin Yang et al.
MOLECULAR MEDICINE REPORTS (2021)
Key Enzymes in Pyrimidine Synthesis, CAD and CPS1, Predict Prognosis in Hepatocellular Carcinoma
Dirk Andreas Ridder et al.
CANCERS (2021)
Argininosuccinate synthase 1 suppresses tumor progression through activation of PERK/eIF2α/ATF4/CHOP axis in hepatocellular carcinoma
Sanghwa Kim et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
NFIB promotes the migration and progression of kidney renal clear cell carcinoma by regulating PINK1 transcription
Ninghua Wang et al.
PEERJ (2021)
Oncogenic KRAS creates an aspartate metabolism signature in colorectal cancer cells
Peter F. Doubleday et al.
FEBS JOURNAL (2021)
Discovery of a Carbamoyl Phosphate Synthetase 1-Deficient HCC Subtype With Therapeutic Potential Through Integrative Genomic and Experimental Analysis
Tong Wu et al.
HEPATOLOGY (2021)
NFI transcription factors provide chromatin access to maintain stem cell identity while preventing unintended lineage fate choices
Rene C. Adam et al.
NATURE CELL BIOLOGY (2020)
Nuclear factor I/B promotes colorectal cancer cell proliferation, epithelial-mesenchymal transition and 5-fluorouracil resistance
ZhengYi Liu et al.
CANCER SCIENCE (2019)
NFIB promotes cell survival by directly suppressing p21 transcription in TP53-mutated triple-negative breast cancer
Rong-Zong Liu et al.
JOURNAL OF PATHOLOGY (2019)
Optimizing combination of liver-enriched transcription factors and nuclear receptors simultaneously favors ammonia and drug metabolism in liver cells
Yongfa Su et al.
EXPERIMENTAL CELL RESEARCH (2018)
Shp2 deletion in hepatocytes suppresses hepatocarcinogenesis driven by oncogenic β-Catenin, PIK3CA and MET
Jacey J. Liu et al.
JOURNAL OF HEPATOLOGY (2018)
NFIB Haploinsufficiency Is Associated with Intellectual Disability and Macrocephaly
Ina Schanze et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2018)
Rewiring urea cycle metabolism in cancer to support anabolism
Rom Keshet et al.
NATURE REVIEWS CANCER (2018)
Role of CPS1 in Cell Growth, Metabolism, and Prognosis in LKB1-Inactivated Lung Adenocarcinoma
Muge Celiktas et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Role of CPS1 in Cell Growth, Metabolism, and Prognosis in LKB1-Inactivated Lung Adenocarcinoma
Muge Celiktas et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
miR-1224 inhibits cell proliferation in acute liver failure by targeting the antiapoptotic gene Nfib
Sanchari Roy et al.
JOURNAL OF HEPATOLOGY (2017)
CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells
Jiyeon Kim et al.
NATURE (2017)
Nuclear Factor I/B: A Master Regulator of Cell Differentiation with Paradoxical Roles in Cancer
Daiana D. Becker-Santos et al.
EBIOMEDICINE (2017)
NFIB Mediates BRN2 Driven Melanoma Cell Migration and Invasion Through Regulation of EZH2 and MITF
Mitchell E. Fane et al.
EBIOMEDICINE (2017)
CRISPR/Cas9 in Genome Editing and Beyond
Haifeng Wang et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 85 (2016)
Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility
Sarah K. Denny et al.
CELL (2016)
Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression
Nicholas F. Evageliou et al.
CLINICAL CANCER RESEARCH (2016)
Nfib Regulates Transcriptional Networks That Control the Development of Prostatic Hyperplasia
Magdalena M. Grabowska et al.
ENDOCRINOLOGY (2016)
Developmental transcription factor NFIB is a putative target of oncofetal miRNAs and is associated with tumour aggressiveness in lung adenocarcinoma
Daiana D. Becker-Santos et al.
JOURNAL OF PATHOLOGY (2016)
Cisplatin-induced synthetic lethality to arginine-starvation therapy by transcriptional suppression of ASS1 is regulated by DEC1, HIF-1a, and c-Myc transcription network and is independent of ASS1 promoter DNA methylation
Yan Long et al.
ONCOTARGET (2016)
microRNA-365-targeted nuclear factor I/B transcriptionally represses cyclin-dependent kinase 6 and 4 to inhibit the progression of cutaneous squamous cell carcinoma
Liang Zhou et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2015)
PTPN11/Shp2 overexpression enhances liver cancer progression and predicts poor prognosis of patients
Tao Han et al.
JOURNAL OF HEPATOLOGY (2015)
Diversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis
Shiran Rabinovich et al.
NATURE (2015)
p53-induced microRNA-1246 inhibits the cell growth of human hepatocellular carcinoma cells by targeting NFIB
Quan Zhang et al.
ONCOLOGY REPORTS (2015)
HIV-1 Induced Nuclear Factor I-B (NF-IB) Expression Negatively Regulates HIV-1 Replication through Interaction with the Long Terminal Repeat Region
Sai Vikram Vemula et al.
VIRUSES-BASEL (2015)
A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma
Lisa Mirabello et al.
CANCER DISCOVERY (2015)
SnapShot: Hepatocellular Carcinoma
Jens U. Marquardt et al.
CANCER CELL (2014)
NFIB-Mediated Repression of the Epigenetic Factor Ezh2 Regulates Cortical Development
Michael Piper et al.
JOURNAL OF NEUROSCIENCE (2014)
NFIB is a governor of epithelial-melanocyte stem cell behaviour in a shared niche
Chiung-Ying Chang et al.
NATURE (2013)
Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma
N. Syed et al.
CELL DEATH & DISEASE (2013)
Reversed argininosuccinate lyase activity in fumarate hydratase-deficient cancer cells
Liang Zheng et al.
CANCER & METABOLISM (2013)
DNA Methylation Suppresses Expression of the Urea Cycle Enzyme Carbamoyl Phosphate Synthetase 1 (CPS1) in Human Hepatocellular Carcinoma
Hongyan Liu et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
MicroRNAs-372/373 Promote the Expression of Hepatitis B Virus Through the Targeting of Nuclear Factor I/B
Hongyan Guo et al.
HEPATOLOGY (2011)
Analysis of genomic aberrations and gene expression profiling identifies novel lesions and pathways in myeloproliferative neoplasms
K. L. Rice et al.
BLOOD CANCER JOURNAL (2011)
Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer
Barbara Delage et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Loss of Carbamoyl Phosphate Synthetase I in Small-Intestinal Adenocarcinoma
Diana M. Cardona et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2009)
Nuclear Factor I transcription factors regulate IGF binding protein 5 gene transcription in human osteoblasts
Laura A. Perez-Casellas et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2009)
Nuclear Factor One Transcription Factors in CNS Development
Sharon Mason et al.
MOLECULAR NEUROBIOLOGY (2009)
Nuclear factor I coordinates multiple phases of cerebellar granule cell development via regulation of cell adhesion molecules
Wei Wang et al.
JOURNAL OF NEUROSCIENCE (2007)
Role of nitric oxide in carcinogenesis and tumour progression
Peeyush K. Lala et al.
LANCET ONCOLOGY (2001)
Share Paper
